Intramedullary Nailing Patents: Who Leads, Where the Gaps Are 2026
Intramedullary Nailing Patents: Filing Trends and Where the Field Is Still Open
30.8% concentration. the five leading assignees combine for 623 of the 2,023 records in scope, but the other 69.2% is spread across a long tail of single- and few-filing entrants. Filings rose from 68 in 2017 to a peak of 125 in 2019, then eased; the 2021-to-2024 window shows a 31% decline (88 to 61 records). 2025 and 2026 figures are still incomplete because publication lags filing by roughly 18 months, so the most recent bars understate real filing activity.
- 1SMITH & NEPHEW INC10.3%
- 2DEPUY SYNTHES PROD INC6.6%
- 3SYNTHES GMBH5.0%
- 4GLOBUS MEDICAL INC4.5%
- 5METAMORPHOSIS GMBH4.3%
See the full intramedullary nailing analysis in Eureka
- The complete ranking, not just the top five
- Every IPC branch with its share of the corpus
- The most-cited records, and where claim space is still thin
Common questions about intramedullary nailing patents
Who holds the most intramedullary nailing patents?
The leading assignee in this dataset holds 209 of the 2,023 records in scope, well ahead of the fifth-ranked assignee at 87 and the tenth at 40. That gradient — a strong leader followed by a steep drop-off rather than a tight cluster — means one company’s filing history dominates the historical record even though the top five combined only reach 30.8% of all records. Recent-year momentum data also shows several of these historical leaders have slowed to zero filings in the latest year, so current activity does not track the same ranking as cumulative volume.
Is intramedullary nailing patent activity growing or shrinking?
Filing peaked at 125 records in 2019 and has since declined; the period from 2021 to 2024 shows a 31% drop, from 88 records down to 61. That said, 2025 and 2026 figures in any dataset like this are always incomplete because publication typically lags actual filing by around 18 months, so the most recent one to two years will look artificially low regardless of true filing activity. The safest read is that the field cooled from its 2019 peak through at least 2024, without over-reading the very latest bars.
What does US8182490B2 actually cover?
US8182490B2 claims an adjustable angle targeting device for an intramedullary nail, filed by Biomet C.V. and published in 2012. Its core mechanism ties a rotational alignment member and a bore with a slot-shaped upper portion to a spherical-surfaced holding member, letting the targeting frame adjust angle while keeping the nail aligned during interlocking screw placement. Anyone designing a targeting jig or guide frame for nail insertion needs to check their bore and alignment-member geometry against this claim structure specifically, not just against the general concept of an angle-adjustable guide.
Disclaimer. This analysis is based on Patsnap Eureka data drawn from a limited snapshot of global patent records and is provided for general information and reference only. Patent data carries inherent limitations — recent filings are under-counted because of publication lag, counts may be on a record or family basis, classification and applicant-name data may contain errors or duplicates, and the underlying search query defines the scope shown — so the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing here is an exhaustive prior-art, novelty, freedom-to-operate or validity search, nor does it constitute legal, financial or professional advice, and it should not be relied upon as such. Verify independently and review with qualified patent and legal professionals before acting on it.
Method: Filing trend and technology composition. Derived from a Patsnap search on Intramedullary Nailing covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish. Every share divides by all records in scope. Data: Patsnap Eureka. See the full landscape report.